Hydroxyprogesterone caproate
- Product NDC
- 71225-105
- 11-digit product format
- 712250105
- Labeler code
- 71225
- Product ID
- 71225-105_2e489a75-b05a-49fa-a08a-071d26e1ba30
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Hydroxyprogesterone caproate
- Dosage form
- INJECTION
- Route
- INTRAMUSCULAR
- Labeler
- Slayback Pharma LLC
- Application
- ANDA210877
- Marketing category
- ANDA
- Marketing start
- 2019-03-25
- Marketing end
- 0000-00-00
- Substance
- HYDROXYPROGESTERONE CAPROATE
- Active strength
- 250 mg/mL
- Pharmacologic classes
- Progesterone Congeners [CS],Progestin [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71225-105-01 | 71225010501 | 1 VIAL, GLASS in 1 CARTON (71225-105-01) > 1 mL in 1 VIAL, GLASS | 2019-03-25 | 0000-00-00 | No | No | Current |